Expert opinion on montelukast and acebrophylline combination in the management of asthma
Asthma control is highly inadequate in India, with worse outcomes and poor adherence to inhaled corticosteroids (ICSs). As per the Global Initiative for Asthma guidelines, leukotriene receptor antagonist (LTRA) can be added when a low-to-moderate dose of ICS does not provide sufficient disease contr...
Main Authors: | N H Krishna, Amita Nene, Mahavir Modi, Tanvir Reza, Ashwin Songara, Vikrant Deshmukh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Allergy Asthma and Immunology |
Subjects: | |
Online Access: | http://www.ijaai.in/article.asp?issn=0972-6691;year=2021;volume=35;issue=2;spage=48;epage=54;aulast=Krishna |
Similar Items
-
The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
by: Johanna Michael, et al.
Published: (2021-03-01) -
Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity
by: Margherita Tassan Mazzocco, et al.
Published: (2023-02-01) -
The Efficacy of Montelukast Monotherapy in Moderate Persistent Asthmatic Children
by: Mahir Igde, et al.
Published: (2009-09-01) -
Therapeutic Effect of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, on Japanese Patients with Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2008-01-01) -
Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta Alessandra, et al.
Published: (2012-07-01)